But substances identified about the illicit or grey markets aren’t particularly standardized. High variability between producers and inaccurate marketing or labeling combine to indicate that “users frequently don’t genuinely know the precise dosages they’re getting,” suggests Aragón. There aren't any specific proves to propose that mi